• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket

    7/21/23 8:13:30 AM ET
    $AHI
    $BGLC
    $BSGM
    $DSS
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical Specialities
    Health Care
    Get the next $AHI alert in real time by email

    Gainers

    • BioNexus Gene Lab Corp (NASDAQ:BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital Market.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) shares gained 21.2% to $0.40 in pre-market trading. Greenbrook TMS recently entered into equity purchase agreement with Alumni Capital LP.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) gained 21% to $16.17 in pre-market trading. Digital World reached settlement with the SEC, paving way for Form S-4 registration statement review.
    • Emergent BioSolutions Inc. (NYSE:EBS) shares gained 16.2% to $8.20 in pre-market trading after the FDA approved the company's two-dose anthrax vaccine for adults.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 15.8% to $0.1159 in pre-market trading. The FDA granted Breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test.
    • Phunware, Inc. (NASDAQ:PHUN) rose 11.5% to $0.4321 in pre-market trading. Phunware recently announced strategic cost saving measures to accelerate path to profitability.
    • POSCO Holdings Inc. (NYSE:PKX) shares rose 11.5% to $108.02 in pre-market trading.
    • LiveWire Group, Inc. (NYSE:LVWR) rose 10.6% to $11.39 in pre-market trading. LiveWire Group is expected to release its second quarter financial results on July 27, 2023.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares climbed 10.2% to $0.32 in pre-market trading. TRACON Pharmaceuticals recently released the results of a six-month independent data monitoring committee (IDMC) review for the ongoing ENVASARC Phase 2 trial.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) gained 9.2% to $7.03 in pre-market trading. Guardforce AI shares jumped 57% on Thursday after the company announced it partnered with Concorde Security to launch a new robotic security solution in Singapore.

    Losers

    • Sigma Additive Solutions, Inc. (NASDAQ:SASI) fell 39.2% to $0.2369 in pre-market trading.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) fell 15.4% to $0.5320 in pre-market trading. Pharmaceuticals received deficiency letter from NASDAQ. The compliance period for the company will expire on Jan. 15, 2024 - 8K.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) fell 10.8% to $0.49 in pre-market trading after gaining 15% on Thursday. Lytus Technologies recently shared updates on progress on its IPTV and Broadband Services.
    • Sirius XM Holdings Inc. (NASDAQ:SIRI) shares fell 9.8% to $7.05 in pre-market trading after gaining 42% on Thursday. Pivotal Research downgraded Sirius XM from Hold to Sell, while Evercore ISI Group analyst Vijay Jayant downgraded the stock from In-Line to Underperform.
    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) shares fell 8.7% to $2.72 in pre-market trading. Eliem Therapeutics shares gained over 6% on Thursday after the company decided to explore strategic alternatives.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) fell 8% to $0.3855 in pre-market trading after gaining 10% on Thursday. Hillstream Biopharma recently expanded its collaboration with Minotaur Therapeutics and its license agreement with OmniAb to advance next-generation targeted knob biologics (picobodies) against HER3 and a new undisclosed oncology target.
    • DSS, Inc. (NYSE:DSS) fell 7.2% to $0.2562 in pre-market trading. DSS recently appointed Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) fell 7.2% to $1.29 in pre-market trading. BioSig shares gained 7% on Thursday after the company's subsidiary was selected to join NVIDIA Inception program to support R&D collaboration on AI medical device platform for hospitals..
    • Advanced Health Intelligence Ltd. (NASDAQ:AHI) shares fell 6.1% to $3.91 in pre-market trading after gaining over 22% on Thursday.
    • Intuitive Surgical, Inc. (NASDAQ:ISRG) fell 4.8% to $331.00 in pre-market. Intuitive Surgical reported better-than-expected earnings for its second quarter.

     

    Now Read This: American Express, SLB And 3 Stocks To Watch Heading Into Friday

    Get the next $AHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHI
    $BGLC
    $BSGM
    $DSS

    CompanyDatePrice TargetRatingAnalyst
    SiriusXM Holdings Inc.
    $SIRI
    2/10/2026$24.00Underweight → Neutral
    Analyst
    SiriusXM Holdings Inc.
    $SIRI
    2/6/2026Buy → Neutral
    Seaport Research Partners
    SiriusXM Holdings Inc.
    $SIRI
    1/27/2026$21.00Neutral
    MoffettNathanson
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Intuitive Surgical Inc.
    $ISRG
    12/11/2025$635.00Buy → Neutral
    Citigroup
    Intuitive Surgical Inc.
    $ISRG
    7/23/2025Buy → Hold
    Erste Group
    POSCO HOLDINGS INC.
    $PKX
    7/7/2025Equal-Weight → Overweight
    Morgan Stanley
    Intuitive Surgical Inc.
    $ISRG
    6/9/2025$440.00Hold → Sell
    Deutsche Bank
    More analyst ratings

    $AHI
    $BGLC
    $BSGM
    $DSS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sirius XM upgraded by Analyst with a new price target

    Analyst upgraded Sirius XM from Underweight to Neutral and set a new price target of $24.00

    2/10/26 7:58:18 AM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Sirius XM downgraded by Seaport Research Partners

    Seaport Research Partners downgraded Sirius XM from Buy to Neutral

    2/6/26 7:53:14 AM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    MoffettNathanson initiated coverage on Sirius XM with a new price target

    MoffettNathanson initiated coverage of Sirius XM with a rating of Neutral and set a new price target of $21.00

    1/27/26 8:49:45 AM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    $AHI
    $BGLC
    $BSGM
    $DSS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel & Board Sec. Gerrard Allen covered exercise/tax liability with 16,481 shares and was granted 101,395 shares, increasing direct ownership by 87% to 183,060 units (SEC Form 4)

    4 - LiveWire Group, Inc. (0001898795) (Issuer)

    2/23/26 9:50:55 PM ET
    $LVWR
    Motor Vehicles
    Consumer Discretionary

    Head of Global Sales & Mktg. Bekefy Jon covered exercise/tax liability with 18,508 shares and was granted 96,567 shares, increasing direct ownership by 68% to 192,770 units (SEC Form 4)

    4 - LiveWire Group, Inc. (0001898795) (Issuer)

    2/23/26 9:50:35 PM ET
    $LVWR
    Motor Vehicles
    Consumer Discretionary

    Head of Product Dev. & Design Ragland Ryan covered exercise/tax liability with 21,625 shares and was granted 96,567 shares, increasing direct ownership by 53% to 216,798 units (SEC Form 4)

    4 - LiveWire Group, Inc. (0001898795) (Issuer)

    2/23/26 9:50:17 PM ET
    $LVWR
    Motor Vehicles
    Consumer Discretionary

    $AHI
    $BGLC
    $BSGM
    $DSS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SiriusXM to Present at the 2026 Morgan Stanley Technology, Media & Telecom Conference

    NEW YORK, Feb. 23, 2026 /PRNewswire/ -- SiriusXM (NASDAQ:SIRI) today announced that Jennifer Witz, Chief Executive Officer will present on March 3, 2025, at 8:30 a.m. PT at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, CA. A webcast of the presentation will be available in the Investor Relations section of the SiriusXM website at https://investor.siriusxm.com. About Sirius XM Holdings Inc.SiriusXM is the leading audio entertainment company in North America with a portfolio of audio businesses including its flagship subscription entertainment service

    2/23/26 4:30:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    Guardforce AI Announces Share Repurchase Program

    NEW YORK, NY,, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ:GFAI, GFAIW)), an AI-driven technology company providing Agentic AI smart solutions in automation, robotics, and secured logistics, today announced that its Board of Directors has approved a Share Repurchase Program with authorization to purchase up to $5 million of the Company's outstanding ordinary shares. This Program, effective immediately and in effect for up to one year from today, reflects the Company's belief that its current market valuation does not fully reflect its intrinsic value, including the strength of its legacy secured logistics business and the long-te

    2/20/26 8:30:00 AM ET
    $GFAI
    Diversified Commercial Services
    Consumer Discretionary

    $AHI
    $BGLC
    $BSGM
    $DSS
    SEC Filings

    View All

    SEC Form 6-K filed by Guardforce AI Co. Limited

    6-K - Guardforce AI Co., Ltd. (0001804469) (Filer)

    2/23/26 3:59:58 PM ET
    $GFAI
    Diversified Commercial Services
    Consumer Discretionary

    Amendment: SEC Form 6-K/A filed by POSCO HOLDINGS INC.

    6-K/A - POSCO HOLDINGS INC. (0000889132) (Filer)

    2/23/26 10:31:08 AM ET
    $PKX
    Steel/Iron Ore
    Industrials

    BioNexus Gene Lab Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - BioNexus Gene Lab Corp (0001737523) (Filer)

    2/23/26 8:35:38 AM ET
    $BGLC
    Medical Specialities
    Health Care

    $AHI
    $BGLC
    $BSGM
    $DSS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Giustra Frank bought $734,725 worth of shares (178,205 units at $4.12) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    9/15/25 8:19:20 PM ET
    $BSGM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    President and CEO Papa Joseph C bought $349,800 worth of shares (60,000 units at $5.83), increasing direct ownership by 21% to 342,500 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    5/15/25 4:02:40 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Stengone Carmine N. bought $4,600 worth of shares (1,250 units at $3.68) (SEC Form 4)

    4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    9/12/24 6:32:55 AM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $BGLC
    $BSGM
    $DSS
    Leadership Updates

    Live Leadership Updates

    View All

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    SiriusXM Appoints Eve Konstan as Executive Vice President, Chief Legal Officer and Secretary

    NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASDAQ:SIRI) today announced the appointment of Eve Konstan as Executive Vice President, Chief Legal Officer and Secretary, effective February 9, 2026. Konstan succeeds Richard N. Baer, who is retiring. Konstan is a distinguished legal mind known for her expertise in media, entertainment, and communications law, with an extensive background advising top companies. Most recently, Konstan served as General Counsel at Spotify Technology S.A, where she supported the organization across all legal matters, including co

    1/29/26 8:00:00 AM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Phunware Announces Appointment of Elliot Han as Chairperson of the Board of Directors

    Experienced Corporate Finance and Technology/Digital-Asset Leader to Guide Board Strategy and Growth Initiatives AUSTIN, Texas, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. ("Phunware" or the "Company") (NASDAQ:PHUN), the enterprise cloud platform for mobile that provides products, solutions, data, and services for brands to engage, manage and monetize global audiences, today announced that Elliot Han was appointed Chairperson of the Company's Board of Directors and Chairperson of the Board's Audit Committee, each effective October 2025. Mr. Han has served as a Class II non-employee Director on the Company's Board since January 2024 and will continue to chair the Board's Compensation

    12/2/25 8:31:00 AM ET
    $PHUN
    EDP Services
    Technology

    $AHI
    $BGLC
    $BSGM
    $DSS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DSS Inc.

    SC 13D/A - DSS, INC. (0000771999) (Subject)

    12/12/24 9:56:52 PM ET
    $DSS
    Containers/Packaging
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by TRACON Pharmaceuticals Inc.

    SC 13G/A - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

    11/14/24 8:51:58 PM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Kiora Pharmaceuticals Inc.

    SC 13G/A - KIORA PHARMACEUTICALS INC (0001372514) (Subject)

    11/14/24 7:17:24 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $BGLC
    $BSGM
    $DSS
    Financials

    Live finance-specific insights

    View All

    Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025. Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of

    2/12/26 9:02:20 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SiriusXM Declares Quarterly Cash Dividend

    NEW YORK, Jan. 29, 2026 /PRNewswire/ -- SiriusXM (NASDAQ:SIRI) today announced that its Board of Directors declared a quarterly cash dividend of $0.27 per share of common stock. This regular quarterly dividend is payable in cash on February 27, 2026, to stockholders of record at the close of business on February 11, 2026. About Sirius XM Holdings Inc.SiriusXM is the leading audio entertainment company in North America with a portfolio of audio businesses including its flagship subscription entertainment service SiriusXM; the ad-supported and premium music streaming services of

    1/29/26 4:30:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    LiveWire Group, Inc. To Report Fourth Quarter and Year-End 2025 Results on February 10, 2026

    Webcast Conference Call Scheduled for 8 a.m. CST LiveWire Group, Inc. (NYSE:LVWR) will release its fourth quarter and year-end financial results before market hours Tuesday, February 10, 2026. The public is invited to attend an audio webcast from 8-9 a.m. CST. LiveWire's financial results, developments in the business, and the Company's outlook will be shared during the Harley-Davidson, Inc. audio webcast. Webcast participants should log-on and register at least 10 minutes prior to the start time and can access the slide presentation here: https://investor.livewire.com/news-events-1/events/default.aspx. A replay of the audio webcast will be available approximately two hours after the ca

    1/26/26 9:30:00 AM ET
    $LVWR
    Motor Vehicles
    Consumer Discretionary